Predictive values of left ventricular mechanical dyssynchrony for CRT response in heart failure patients with

Zhuo He1, Dianfu Li2, Chang Cui2

  • 1Department of Applied Computing, Michigan Technological University, 1400 Townsend Dr, Houghton, MI, 49931, USA.

Insights

Cardiac resynchronization therapy (CRT) response varies by heart condition. Optimal LV lead placement improves outcomes in dilated cardiomyopathy (DCM) but not ischemic cardiomyopathy (ICM) patients.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Cardiac resynchronization therapy (CRT) effectiveness can be influenced by underlying heart conditions.
  • Different pathophysiologies may lead to varying degrees of mechanical dyssynchrony and impact CRT outcomes.

Purpose of the Study:

  • To investigate the relationship between left ventricular (LV) lead placement concordance and CRT response in patients with dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM).
  • To identify predictors of CRT response specific to DCM and ICM.
  • To compare CRT response rates based on LV lead positioning in relation to mechanical dyssynchrony.

Main Methods:

  • Retrospective study of 92 DCM and 50 ICM patients undergoing CRT.
  • Gated single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) used to assess mechanical dyssynchrony.
  • Patients classified into 'both match', 'one match', or 'neither group' based on LV lead position relative to latest contraction/relaxation.
  • CRT response defined as improvement in LV ejection fraction at 6-month follow-up.

Main Results:

  • CRT response rates were 58.7% for DCM and 54% for ICM.
  • In DCM, QRS duration, systolic/diastolic phase bandwidth (PBW), diastolic phase histogram standard deviation (PSD), and LV mechanical dyssynchrony (LVMD) concordance predicted response.
  • In ICM, diabetes mellitus and LV end-systolic volume were associated with response.
  • The 'both match' group showed significantly higher CRT response in DCM (94%) compared to ICM (62%).

Conclusions:

  • Systolic PBW, diastolic PBW, and PSD are better predictors of CRT response in DCM than ICM.
  • Optimizing LV lead placement to match latest contraction and relaxation improves outcomes in DCM patients.
  • This lead placement strategy does not show similar benefits for ICM patients.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
77
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
57
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
105
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74